Mustang Bio, Inc.
MBIO
$0.74
$0.045.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -955.00K | -538.00K | -468.00K | -762.00K | -153.00K |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 0.00 | 41.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.00K | -435.00K | -375.00K | -751.00K | -841.00K |
| Change in Net Operating Assets | 1.00K | -745.00K | 25.00K | 174.00K | -436.00K |
| Cash from Operations | -1.01M | -1.72M | -818.00K | -1.34M | -1.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 1.17M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 1.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 7.15M | -- | 7.62M |
| Repurchase of Common Stock | -- | -- | -- | -235.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 7.15M | -235.00K | 7.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.01M | -1.72M | 6.33M | -1.57M | 7.39M |